Your browser doesn't support javascript.
loading
CRLF3 plays a key role in the final stage of platelet genesis and is a potential therapeutic target for thrombocythemia.
Bennett, Cavan; Lawrence, Moyra; Guerrero, Jose A; Stritt, Simon; Waller, Amie K; Yan, Yahui; Mifsud, Richard W; Ballester-Beltrán, Jose; Baig, Ayesha; Mueller, Annett; Mayer, Louisa; Warland, James; Penkett, Christopher J; Akbari, Parsa; Moreau, Thomas; Evans, Amanda L; Mookerjee, Souradip; Hoffman, Gary J; Saeb-Parsy, Kourosh; Adams, David J; Couzens, Amber L; Bender, Markus; Erber, Wendy N; Nieswandt, Bernhard; Read, Randy J; Ghevaert, Cedric.
Afiliação
  • Bennett C; Department of Haematology, Cambridge Blood Centre, National Health Service Blood and Transplant, University of Cambridge, Cambridge, United Kingdom.
  • Lawrence M; Department of Haematology, Cambridge Blood Centre, National Health Service Blood and Transplant, University of Cambridge, Cambridge, United Kingdom.
  • Guerrero JA; Jeffrey Cheah Biomedical Centre, Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.
  • Stritt S; Department of Haematology, Cambridge Blood Centre, National Health Service Blood and Transplant, University of Cambridge, Cambridge, United Kingdom.
  • Waller AK; Institute of Experimental Biomedicine, University Hospital, University of Würzburg, Würzburg, Germany.
  • Yan Y; Department of Haematology, Cambridge Blood Centre, National Health Service Blood and Transplant, University of Cambridge, Cambridge, United Kingdom.
  • Mifsud RW; Jeffrey Cheah Biomedical Centre, Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.
  • Ballester-Beltrán J; Department of Haematology, Cambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom.
  • Baig A; Department of Haematology, Cambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom.
  • Mueller A; Department of Haematology, Cambridge Blood Centre, National Health Service Blood and Transplant, University of Cambridge, Cambridge, United Kingdom.
  • Mayer L; Institute of Experimental Biomedicine, University Hospital, University of Würzburg, Würzburg, Germany.
  • Warland J; Department of Haematology, Cambridge Blood Centre, National Health Service Blood and Transplant, University of Cambridge, Cambridge, United Kingdom.
  • Penkett CJ; Jeffrey Cheah Biomedical Centre, Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.
  • Akbari P; Department of Haematology, Cambridge Blood Centre, National Health Service Blood and Transplant, University of Cambridge, Cambridge, United Kingdom.
  • Moreau T; Department of Haematology, Cambridge Blood Centre, National Health Service Blood and Transplant, University of Cambridge, Cambridge, United Kingdom.
  • Evans AL; Jeffrey Cheah Biomedical Centre, Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.
  • Mookerjee S; Department of Haematology, Cambridge Blood Centre, National Health Service Blood and Transplant, University of Cambridge, Cambridge, United Kingdom.
  • Hoffman GJ; Medical Research Council/British Heart Foundation Cardiovascular Epidemiology Unit, Strangeways Research Laboratory, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
  • Saeb-Parsy K; Department of Human Genetics, Wellcome Trust Sanger Institute, Cambridge, United Kingdom.
  • Adams DJ; Department of Haematology, Cambridge Blood Centre, National Health Service Blood and Transplant, University of Cambridge, Cambridge, United Kingdom.
  • Couzens AL; Department of Haematology, Cambridge Blood Centre, National Health Service Blood and Transplant, University of Cambridge, Cambridge, United Kingdom.
  • Bender M; Jeffrey Cheah Biomedical Centre, Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.
  • Erber WN; Department of Haematology, Cambridge Blood Centre, National Health Service Blood and Transplant, University of Cambridge, Cambridge, United Kingdom.
  • Nieswandt B; Jeffrey Cheah Biomedical Centre, Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.
  • Read RJ; Faculty of Health and Medical Sciences, Medical School, University of Western Australia, Crawley, WA, Australia.
  • Ghevaert C; Department of Surgery, NIHR Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, United Kingdom.
Blood ; 139(14): 2227-2239, 2022 04 07.
Article em En | MEDLINE | ID: mdl-35051265
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Plaquetas / Trombocitemia Essencial Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Plaquetas / Trombocitemia Essencial Idioma: En Ano de publicação: 2022 Tipo de documento: Article